Effectiveness of three different doses of Carvedilol for exertional angina

American Journal of Cardiology

Volumn 82, Issue 8, 1998, Pages 927-931

  Weiss, Robert ^a,b   Ferry, David ^a   Pickering, Edward ^a   Smith, L Kent ^a   Dennish III, George ^a   Krug Gourley, Sue ^a   Lukas, Mary Ann ^a  

^a Androscoqqin Cardiology Associates   (United States)

^b Androscoggin Cardiology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HEART EJECTION FRACTION; HUMAN; HYPOTENSION; LUNG WEDGE PRESSURE; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

AGED; ANGINA PECTORIS; CARBAZOLES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROPANOLAMINES; VASODILATOR AGENTS;

EID: 0032532401     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00507-4     Document Type: Article

References (13)

1. Ruffolo RR Jr, Sauermelch CF, Willette RN. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation. Eur J Clin Pharmacol 1990;38:S112-114.
2. Hattori Y, Nakaya H, Endou M, Nakao Y, Kanno M. Vascular effects of carvedilol, a new beta-adrenoreceptor antagonist with vasodilating properties, in isolated canine coronary artery. J Cardiovasc Pharmacol 1989;13:572-579.
3. Belz GG, Beermann C, Schloos J, Neugebauer G. Influence of carvedilol on the responsiveness of human hand veins to noradrenaline and dinoprost. Drugs 1988;36(suppl 6):69-74.
4. Lahiri A, Rodriques EA, Al Khawaja I, Raftery EB. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris. Am J Cardiol 1987;59:769-774.
5. Wendt T, van der Does R, Schroder R, Landgraf H, Kober G. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol. J Cardiovasc Pharmacol 1987;10(suppl 11):S147-150.
6. Buhite, SG. Use of the extended-period latin square design in clinical trials. Am Statis Assoc Proc 1987:237-242.
7. SAS Institute Inc. SAS/STAT User's Guide. Version 6, 4th ed. Cary, NC: 1990;1-2.
8. Weiss RJ, Zeller E, Ashley W, Brundage B, Burger AJ, Touchon R. Lack of anti-anginal efficacy of labetalol in normotensive patients. Circulation 1986:74: 11-501.
9. Giannattasio C, Cattaneo BM, Seravalle G, Carugo S, Mangoni AA, Grassi G, Zanchetti A, Manica G. Alpha-1 blocking properties of carvedilol during acute and chronic administration. J Cardiovasc Pharmacol 1992; 19(Suppl 1):S18-S22.
10. Kohli RS, Khurmi NS, Kardash MM, Hughes LO, Lahiri A, Raftery EB. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up. Am J Cardiol 1984;53:684-688.
11. Rodrigues EA, Lahiri A, Hughes LO, Kohli RS, Whittington JR, Raftery EB. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity. Am J Cardiol 1986;58:916-921.
12. Freedman SB, Jamal SM, Harris PJ, Kelly DT. Comparison of carvedilol and atenolol for angina pectoris. Am J Cardiol 1987;60:499-502.
13. van der Does R, Eberhardt R, Derr I, Ehmer B. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina. J Cardiovasc Pharmacol 1992;19(Suppl 1):S122-127.